000 01486 a2200409 4500
005 20250514073658.0
264 0 _c20040430
008 200404s 0 0 eng d
022 _a1466-4860
024 7 _a10.1038/sj.thj.6200251
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHomewood, Janis
245 0 0 _aTreatment of CML using IFN-alpha: impact on quality of life.
_h[electronic resource]
260 _bThe hematology journal : the official journal of the European Haematology Association
_c2003
300 _a253-62 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCognition
_xdrug effects
650 0 4 _aCross-Sectional Studies
650 0 4 _aDrug Evaluation
650 0 4 _aDyspnea
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xcomplications
650 0 4 _aPain
650 0 4 _aQuality of Life
650 0 4 _aRandom Allocation
650 0 4 _aSelf-Assessment
650 0 4 _aSexual Behavior
_xdrug effects
650 0 4 _aSocial Behavior
650 0 4 _aSurveys and Questionnaires
700 1 _aWatson, Maggie
700 1 _aRichards, Sue M
700 1 _aHalsey, Jim
700 1 _aShepherd, Pat C A
773 0 _tThe hematology journal : the official journal of the European Haematology Association
_gvol. 4
_gno. 4
_gp. 253-62
856 4 0 _uhttps://doi.org/10.1038/sj.thj.6200251
_zAvailable from publisher's website
999 _c12649660
_d12649660